Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria.
about
Mycobacterial outer membranes: in search of proteinsA balancing act: efflux/influx in mycobacterial drug resistanceSnake Venom: Any Clue for Antibiotics and CAM?Crystal Structures of Multidrug Binding Protein TtgR in Complex with Antibiotics and Plant AntimicrobialsDomain Cross-talk during Effector Binding to the Multidrug Binding TTGR RegulatorStructural and functional analysis of the transcriptional regulator Rv3066 of Mycobacterium tuberculosisCrystal structure of the transcriptional regulator Rv1219c ofMycobacterium tuberculosisUse of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance?Identification of a novel multidrug efflux pump of Mycobacterium tuberculosisRv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discoveryChemical communication of antibiotic resistance by a highly resistant subpopulation of bacterial cellsA novel marRAB operon contributes to the rifampicin resistance in Mycobacterium smegmatisMolecular basis of bacterial outer membrane permeability revisitedA critical review on ultrasensitive, spectroscopic-based methods for high-throughput monitoring of bacteria during infection treatment.Factors affecting the folding of Pseudomonas aeruginosa OprF porin into the one-domain open conformerWeakening effect of cell permeabilizers on gram-negative bacteria causing biodeteriorationThe ATP binding cassette multidrug transporter LmrA and lipid transporter MsbA have overlapping substrate specificities.Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome.Antibiotic stress, genetic response and altered permeability of E. coli.The neglected intrinsic resistome of bacterial pathogens.Exploring the HME and HAE1 efflux systems in the genus BurkholderiaCharacterization of novel Mycobacterium tuberculosis and Mycobacterium smegmatis mutants hypersusceptible to beta-lactam antibiotics.Ethidium bromide transport across Mycobacterium smegmatis cell-wall: correlation with antibiotic resistancePhotodynamic inactivation of bacteria using polyethylenimine-chlorin(e6) conjugates: Effect of polymer molecular weight, substitution ratio of chlorin(e6) and pH.Correlation between ceftriaxone resistance of Salmonella enterica serovar Typhimurium and expression of outer membrane proteins OmpW and Ail/OmpX-like protein, which are regulated by BaeR of a two-component system.Screening of a Leptospira biflexa mutant library to identify genes involved in ethidium bromide tolerance.Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops.Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeaeAre natural products still the best source for antibacterial discovery? The bacterial entry factor.Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from TurkeyEvolution and spread of antibiotic resistance.Functional characterization of two defensin isoforms of the hard tick Ixodes ricinus.Whole genome and transcriptome analyses of environmental antibiotic sensitive and multi-resistant Pseudomonas aeruginosa isolates exposed to waste water and tap water.Importance of porins for biocide efficacy against Mycobacterium smegmatisThe Mycobacterium tuberculosis outer membrane channel protein CpnT confers susceptibility to toxic moleculesAcrB multidrug efflux pump of Escherichia coli: composite substrate-binding cavity of exceptional flexibility generates its extremely wide substrate specificity.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Analysis of Clostridium beijerinckii NCIMB 8052's transcriptional response to ferulic acid and its application to enhance the strain tolerance.Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei.Registration of disinfectants based on relative microbicidal activity.
P2860
Q22251442-BFE1ECE9-434A-44C3-89D2-9C1C57C026FAQ24644870-A7A08537-BA0B-4ABB-AFB0-4D53281A9FEBQ24795261-B1A2A28F-767B-4F41-8416-60F65378BC94Q27644626-D0262FDD-CE0F-47BB-829C-0415CE833E8CQ27661156-4C39270F-C537-4A47-A4DE-E36E7AAA121CQ27670866-D9BF02F5-B8FE-49C9-86D0-59C259AE08EFQ27681336-659B6D77-1986-45CF-B816-EAF683EF338FQ28265803-EE3DD243-C3CB-47F7-A8CE-F237B6418525Q28487052-2FDE759D-B45D-4C9F-94C6-079EE1BD1249Q28487552-52B32728-221D-449E-8C7E-DF5FC89E0440Q28534500-EE332841-932E-4320-BA57-4220997CF622Q28542545-11F97352-075A-4CB3-8A63-52E9C7D89F65Q29616208-AD4FC9EE-E275-4A33-B752-DD22E486DA22Q30145562-B6A6BA41-41A3-4D82-973A-B138EDD36A86Q30155978-38817311-5477-4FC2-A679-75374687385BQ30398792-0F24562F-3ADC-4109-A808-D6854935994CQ33187645-9A831D7D-409C-4346-B8D0-460A4E14BB13Q33251206-E71D9436-1A87-408F-830D-E55B49EC6455Q33281751-8E08DF97-E5DE-4DCE-924E-5DC27532A182Q33320525-7C06DC1F-E77B-432E-8EE4-FA006AA01910Q33595044-3BF5AAF8-A2D2-4278-9574-7FEAE001E9DBQ33714602-0DFEFC36-DA34-46B0-8688-4C30D21EBA1AQ33824169-8DC06830-EA8E-41B8-8E54-FB37CD2D5D2CQ33875363-AE895DC4-8EB8-4BF1-8BA8-35F6D8648357Q33935488-B0BABF53-177E-4CC7-97E3-00720F105386Q34261295-7AC7D076-7D95-4C4F-84AA-ECC27D7B68C1Q34320714-06589BA0-706D-4D29-963C-2CE272D890C0Q34436820-C364D941-3A29-45E3-876A-6D990E9E24CEQ34619268-50B42634-A787-4EE7-9E78-F3D5055F9115Q34782401-D14EECDD-7AFF-4C2E-B428-FB6D2896CEE0Q34792403-53D7C27D-EF74-45DD-B791-ED22F74B59E8Q35009172-81F63BD2-E4CC-4FFE-84D6-04F1531990B2Q35062974-258A2BC4-8470-4758-AAC1-6CD53A10C7D4Q35077272-CAC2EB91-7A71-42C9-8EB4-8B6B22A80B4CQ35168922-22351CE1-86F8-4231-9EAD-D4BE9FB7F7B6Q35226455-6478B791-439A-41C2-9AF7-9602C42DA07CQ35482558-2E33C9CF-DFC2-472A-85AA-6C48F4D6BA20Q35523171-83ED57A6-968E-4D28-A08A-1DAEABD1E114Q35635978-F4A9A780-DE20-41A1-9BC6-8448669E6E41Q35755953-F5BB77F2-60AC-4350-90C6-2795F416AC69
P2860
Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Preventing drug access to targ ...... and active efflux in bacteria.
@ast
Preventing drug access to targ ...... and active efflux in bacteria.
@en
Preventing drug access to targ ...... and active efflux in bacteria.
@nl
type
label
Preventing drug access to targ ...... and active efflux in bacteria.
@ast
Preventing drug access to targ ...... and active efflux in bacteria.
@en
Preventing drug access to targ ...... and active efflux in bacteria.
@nl
prefLabel
Preventing drug access to targ ...... and active efflux in bacteria.
@ast
Preventing drug access to targ ...... and active efflux in bacteria.
@en
Preventing drug access to targ ...... and active efflux in bacteria.
@nl
P356
P1476
Preventing drug access to targ ...... and active efflux in bacteria.
@en
P2093
P304
P356
10.1006/SCDB.2000.0247
P577
2001-06-01T00:00:00Z